البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: VMD (Veterinary Medicines Directorate)
Marbofloxacin
CP Pharma Handelsgesellschaft mbH
QJ01MA93
Marbofloxacin
Tablet
POM-V - Prescription Only Medicine – Veterinarian
Cats, Dogs
Antimicrobial
Expired
2013-03-27
Revised: September 2014 AN: 00361/2014 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Marbotab P 20 mg tablets for dogs and cats List of agreed names in the Member States where product is authorized. Italy, Germany, France, The Netherlands, Belgium, Hungary Marbotab P 20 mg tablets for dogs and cats Denmark Marbotab P, 20 mg tablets, for dogs and cats United Kingdom, Ireland, Poland, Spain, Austria Marbotab P, 20 mg tablets for dogs and cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE: Marbofloxacin 20 mg EXCIPIENTS: For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Beige tablets with white speckled, cross-snap-tab. The tablets can be divided into quarters. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs, cats Revised: September 2014 AN: 00361/2014 Page 2 of 7 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of infections caused by strains of microorganisms susceptible to marbofloxacin. IN DOGS: Skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis); Urinary tract infections (UTI) associated or not with prostatitis; Respiratory tract infections. IN CATS: Skin and soft tissue infections (wounds, abscesses, phlegmons); Upper respiratory tract infections. See section 5.1, Pharmacodynamic properties for further information on specific target pathogens. 4.3 CONTRAINDICATIONS Marbofloxacin should not be used in dogs aged less than 12 months, or less than 18 months for exceptionally large breeds of dogs, such as Great Danes, Briard, Bernese Bonvier and Mastiffs, with a longer growth period. Do not use in cats aged less than 16 weeks. Do not use in cases of hypersensitivity to fluoroquinolones or any of the excipients of the product. Do not use in case of resistance against quinolones, since (almost) complete cross-resistance exists against and other fluoroquinolones. Not suitable for infections resulting from strict anaerobes, ye اقرأ الوثيقة كاملة